Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Alzamend Neuro Inc

ALZN
Current price
2.12 USD -0.06 USD (-2.75%)
Last closed 2.19 USD
ISIN US02262M3088
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 976 913 USD
Yield for 12 month -94.18 %
1Y
3Y
5Y
10Y
15Y
ALZN
21.11.2021 - 28.11.2021

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. The company has partnership agreement with Massachusetts General Hospital for the Phase II clinical trial of AL001. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia. Address: 3480 Peachtree Road NE, Atlanta, GA, United States, 30326

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

50 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

+76 110 USD

Last Quarter

Current Year

-50 740 USD

Last Year

-23 066 USD

Current Quarter

+63 425 USD

Last Quarter

-12 685 USD

Key Figures ALZN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -9 886 905 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -189.73 %
PEG Ratio
Return On Equity TTM -4408.31 %
Wall Street Target Price 50 USD
Revenue TTM
Book Value -3.77 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -147 USD
Diluted Eps TTM -147 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ALZN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ALZN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 16.07.2024
Dividend Date

Stock Valuation ALZN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -3.1332
Price Book MRQ 7.2255

Financials ALZN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ALZN

For 52 weeks

1.84 USD 44.85 USD
50 Day MA 3.44 USD
Shares Short Prior Month 17 147
200 Day MA 7.38 USD
Short Ratio 0.49
Shares Short 25 874
Short Percent 4.06 %

Dynamics of changes in the value of assets

U

URANF

0.034 USD International Prospect Ventures Ltd 0 (0%)
Detailed analytics
C

CMPG

255.00 GBX CT Global Managed Portfolio Trust PLC 0 (0%)
Detailed analytics
P

POTRF

0.0010 USD SOPerior Fertilizer Corp 0 (0%)
Detailed analytics
F

FLMTF

0.017 USD Full Metal Minerals Ltd 0 (0%)
Detailed analytics
0

0299

0.13 HKD Glory Sun Land Group Ltd -0 (-3.85%)
Detailed analytics